Mesa Laboratories, Inc. (MLAB) to Issue Quarterly Dividend of $0.16 on December 15th
Mesa Laboratories, Inc. (NASDAQ:MLAB) declared a quarterly dividend on Tuesday, October 3rd, Wall Street Journal reports. Shareholders of record on Thursday, November 30th will be paid a dividend of 0.16 per share by the medical instruments supplier on Friday, December 15th. This represents a $0.64 annualized dividend and a yield of 0.48%. The ex-dividend date of this dividend is Wednesday, November 29th.
Mesa Laboratories has raised its dividend by an average of 3.9% annually over the last three years. Mesa Laboratories has a payout ratio of 25.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Mesa Laboratories to earn $2.46 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 26.0%.
Shares of Mesa Laboratories (NASDAQ MLAB) opened at $134.28 on Tuesday. The stock has a market cap of $499.57, a price-to-earnings ratio of 34.97 and a beta of 0.49. Mesa Laboratories has a 52 week low of $113.57 and a 52 week high of $169.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.86 and a quick ratio of 1.97.
Mesa Laboratories (NASDAQ:MLAB) last issued its earnings results on Monday, November 6th. The medical instruments supplier reported $0.60 EPS for the quarter, missing the consensus estimate of $0.64 by ($0.04). The firm had revenue of $22.95 million during the quarter, compared to the consensus estimate of $25.50 million. Mesa Laboratories had a return on equity of 14.77% and a net margin of 11.48%. research analysts expect that Mesa Laboratories will post 2.47 EPS for the current year.
Several research analysts recently commented on the company. BidaskClub cut Mesa Laboratories from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 12th. TheStreet cut Mesa Laboratories from a “b” rating to a “c+” rating in a report on Monday, July 31st. Finally, Zacks Investment Research raised Mesa Laboratories from a “strong sell” rating to a “buy” rating and set a $167.00 price objective for the company in a report on Tuesday, October 3rd.
ILLEGAL ACTIVITY NOTICE: “Mesa Laboratories, Inc. (MLAB) to Issue Quarterly Dividend of $0.16 on December 15th” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.dailypolitical.com/2017/11/28/mesa-laboratories-inc-mlab-to-issue-quarterly-dividend-of-0-16-on-december-15th.html.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.
Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.